James HodginsFor your info, he's scheduled to be on Market Call on Thursday. Below are his comments from the last time he was on. GLTA
MSL-T 2016-03-29 TOP PICK James Hodgins
This owns a portfolio of drugs in Europe. Because the European market is already very highly regulated, they don’t have the same issues with pricing that others have. Very stable margins. They just raised $25 million at $1.90 through sub receipts. When that closes, they can be swapped for shares in the stock will go back to $1.90. There is the short term upside, but longer-term he loves the growth profile.
Login to show your approval Login to show your disapproval / Be the first to comment
Price:
$1.820
Subject:
MARKET NEUTRAL INVESTING: SMALL/MID-CAP
Bias:
BEARISH
Owned:
Yes